In Africa, only 20% of the population has received full doses of Covid-19 vaccines compared to the global average of over 60%, the vaccination efforts have faced significant challenges.1 Initially, the continent encountered difficulties with inconsistent and unequal access to vaccine supplies, hindering the progress of vaccination campaigns. However, as the situation evolved, the main obstacles shifted to complex delivery logistics, limited access to vaccination centers, and persisting demand barriers, including vaccine hesitancy, and declining concerns about Covid-19 infection. 

The Vaccination Action Network (VAN) has a clear objective: to support decision-makers in comprehending the underlying factors driving vaccination and to facilitate initiatives that enhance Covid-19 vaccine uptake. VAN is a locally-led, peer-to-peer learning initiative designed to improve health systems across sub-Saharan Africa while scaling demand for Covid-19 vaccines. Additionally, VAN aims to strengthen routine immunization programs, thereby equipping health systems to respond effectively to future pandemics. By addressing these multifaceted challenges, VAN endeavors to bridge the gap in vaccination rates and bolster the resilience of healthcare systems in preparation for future health crises.  

Between December 2021 and December 2022, with support from Dalberg, The Rockefeller Foundation, Amref Health Africa, and Sabin Vaccine Institute, VAN has supported decision-makers in Kenya, Malawi, Tanzania, Uganda, Zambia, and Zimbabwe to identify Covid-19 vaccine demand challenges and co-create action projects that address them.

Dalberg has partnered with VAN to produce a report that summarizes the lessons learned for action on COVID-19 vaccination uptake. This report highlights VAN members’ successes, challenges, and impact in the year since the Network’s launch. 

The program is now owned and operated by Africa CDC in conjunction with Rockefeller Foundation. 

Click here to download the report.